Business Update

Blood products group predicts big profit jump for year to June 30

Published in Blood Weekly, August 26th, 2004

Australian blood products group CSL Ltd. forecast a threefold increase in profit for the fiscal year that ended June 30 thanks to proceeds from the sale of its Animal Health unit.

However, the company's stock slumped in early trading because analysts had predicted even stronger earnings.

CSL, one of the world's leading makers of blood plasma products, said it expects net profit of between 210 million Australian dollars (US$147 million) and A$220 million (US$154 million) for fiscal year 2004, up from A$70.4 million the year before.

Profit would be boosted by a gain of A$75 million (US$52.5 million) from the sale of the Animal...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (2004-08-26)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry